Solutions
Life Science
Scaling innovation in life sciences
About Fortunedex Life Sciences
With a focus on businesses that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs, Fortunedex Life Sciences invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies globally. The unique skill set of the Fortunedex Life Sciences team enables it to provide targeted finance and strategic support with additional value to businesses through key growth and value inflection points.
Fortunedex has used a strategic and analytical approach from the company’s founding to find appealing investment possibilities and work with management teams to develop and enhance their companies. Fortunedex has grown its worldwide reach, depth of knowledge, and track record in the life sciences sectors across private equity, public equity, credit, venture capital, and real estate over this time.

By the Numbers
$4.6B
Assets Under Management
As of September 30 2021
51
Investments
Globally, across diagnostics & life sciences tools, medical devices, and biotechnology and pharmaceuticals
80
Trials Funded
To help improve the lives of patients with medical needs
34
Board Positions
From the start of investment
All figures as of December 2023 unless otherwise noted.
Strategy
Ergo Partners Life Sciences targets four types of investment opportunities:

Inflection Capital
Engaging with companies at the critical development stages of innovation.

Growth Capital
Partnering with companies to accelerate and expand platforms.

Fallen Angels
Engaging with companies at a crossroads to create value

Larger Private Equity Collaborations and New Company Formation
Leveraging on Fortunedex to invest in, build and support companies.
All figures as of December 2023 unless otherwise noted.
Investments
Globally, Fortunedex Life Sciences seeks to invest in pharmaceutical, biotechnology, medical device, diagnostic, and life science instrument firms.
